Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura

被引:66
作者
Fabris, F
Tassan, T
Ramon, R
Carraro, G
Randi, ML
Luzzatto, G
Moschino, P
Girolami, A
机构
[1] Univ Padua, Sch Med, Dept Med & Surg Sci, I-35100 Padua, Italy
[2] Padua City Hosp, Div Gen Surg 2, Padua, Italy
关键词
immune thrombocytopenia; splenectomy; predictive factors; age; IVGG;
D O I
10.1046/j.1365-2141.2001.02615.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sixty-one consecutive patients undergoing splenectomy for chronic immune thrombocytopenia were retrospectively evaluated. Platelet response was considered as complete (CR) when platelet count rose to > 100 x 10(9)/ 1, partial (PR) when 30-100 x 10(9)/l or absent (NR) if otherwise. Follow-up (mean time 7.6 years) was possible in 54 patients. Forty-eight patients (88%) had an immediate response to splenectomy (39 CR, 9 PR) whereas six (12%) were NR. Thirty-six responders (67%) had sustained remission (31 CR, 5 PR) without further treatment; thrombocytopenia recurred in 12 patients (33%). The probability curve of continued remission showed a constant relapse-rate during the first 36 months; a further step of relapse was observed beginning 70 months after surgery. The only positive predictive factor for the long-term response to splenectomy was age <40 (P < 0.005). Neither duration of thrombocytopenia nor previous response to medical treatment (steroids and/or intravenous immunoglobulins) were related to splenectomy response.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 12 条
  • [1] CORTELAZZO S, 1991, BLOOD, V77, P31
  • [2] Fabris F, 1997, NEW ENGL J MED, V337, P1088
  • [3] FENAUX P, 1989, EUR J HAEMATOL, V42, P259
  • [4] Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
    George, JN
    Woolf, SH
    Raskob, GE
    Wasser, JS
    Aledort, LM
    Ballem, PJ
    Blanchette, VS
    Bussel, JB
    Cines, DB
    Kelton, JG
    Lichtin, AE
    McMillan, R
    Okerbloom, JA
    Regan, DH
    Warrier, I
    [J]. BLOOD, 1996, 88 (01) : 3 - 40
  • [5] Treatment options for chronic idiopathic (immune) thrombocytopenic purpura
    George, JN
    [J]. SEMINARS IN HEMATOLOGY, 2000, 37 (01) : 31 - 34
  • [6] MECHANISMS OF RESPONSE TO TREATMENT IN AUTOIMMUNE THROMBOCYTOPENIC PURPURA
    GERNSHEIMER, T
    STRATTON, J
    BALLEM, PJ
    SLICHTER, SJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (15) : 974 - 980
  • [7] LACK OF USEFUL CLINICAL PREDICTORS OF RESPONSE TO SPLENECTOMY IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
    JULIA, A
    ARAGUAS, C
    ROSSELLO, J
    BUENO, J
    DOMENECH, P
    OLONA, M
    GUARDIA, R
    PETIT, J
    FLORES, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) : 250 - 255
  • [8] High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura
    Law, C
    Marcaccio, M
    Tam, P
    Heddle, N
    Kelton, JG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (21) : 1494 - 1498
  • [9] Mazzucconi MG, 1999, EUR J HAEMATOL, V62, P219
  • [10] MCMILLAN R, 1994, THROMBOSIS HEMORRHAG, P575